CA2574895A1

CA2574895A1 - Ligands d'acide nucleique

Ligands d'acide nucleique Download PDF

Info

Publication number: CA2574895A1
Authority: CA; Canada
Prior art keywords: nucleic acid; ligand; target; binding; nucleic acids
Prior art date: 1990-06-11
Legal status : Abandoned

Application number

CA002574895A

Other languages

English (en)

Inventor

Larry Gold

Craig Tuerk

Current Assignee

Gilead Sciences Inc

Original Assignee

Individual

Priority date

1990-06-11

Filing date

1991-06-10

Publication date

1991-12-26

1991-06-10 Application filed by Individual filed Critical Individual

1991-06-10 Priority claimed from CA002084987A external-priority patent/CA2084987C/fr

1991-12-26 Publication of CA2574895A1 publication Critical patent/CA2574895A1/fr

Status Abandoned legal-status Critical Current

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 655
102000039446 nucleic acids Human genes 0.000 title claims abstract description 603
108020004707 nucleic acids Proteins 0.000 title claims abstract description 603
239000003446 ligand Substances 0.000 title claims abstract description 468
238000000034 method Methods 0.000 claims abstract description 360
239000000203 mixture Substances 0.000 claims abstract description 243
238000000638 solvent extraction Methods 0.000 claims abstract description 37
230000009870 specific binding Effects 0.000 claims abstract description 21
-1 nucleic acid compounds Chemical class 0.000 claims abstract description 9
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 430
238000009739 binding Methods 0.000 claims description 296
230000027455 binding Effects 0.000 claims description 292
108090000623 proteins and genes Proteins 0.000 claims description 261
102000004169 proteins and genes Human genes 0.000 claims description 255
235000018102 proteins Nutrition 0.000 claims description 224
239000002773 nucleotide Substances 0.000 claims description 107
125000003729 nucleotide group Chemical group 0.000 claims description 107
108020004414 DNA Proteins 0.000 claims description 97
230000006870 function Effects 0.000 claims description 76
230000003321 amplification Effects 0.000 claims description 71
238000003199 nucleic acid amplification method Methods 0.000 claims description 71
230000008569 process Effects 0.000 claims description 67
102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 54
238000012360 testing method Methods 0.000 claims description 41
102000012479 Serine Proteases Human genes 0.000 claims description 35
108010022999 Serine Proteases Proteins 0.000 claims description 35
102000053602 DNA Human genes 0.000 claims description 34
230000000694 effects Effects 0.000 claims description 34
102000005962 receptors Human genes 0.000 claims description 34
108020003175 receptors Proteins 0.000 claims description 34
102000004190 Enzymes Human genes 0.000 claims description 32
108090000790 Enzymes Proteins 0.000 claims description 32
229940088597 hormone Drugs 0.000 claims description 32
239000005556 hormone Substances 0.000 claims description 32
229940088598 enzyme Drugs 0.000 claims description 31
108091028043 Nucleic acid sequence Proteins 0.000 claims description 30
239000003112 inhibitor Substances 0.000 claims description 27
230000015572 biosynthetic process Effects 0.000 claims description 23
108090000765 processed proteins & peptides Proteins 0.000 claims description 23
239000000758 substrate Substances 0.000 claims description 23
238000000338 in vitro Methods 0.000 claims description 22
238000002955 isolation Methods 0.000 claims description 22
230000003197 catalytic effect Effects 0.000 claims description 19
210000004027 cell Anatomy 0.000 claims description 19
102000044158 nucleic acid binding protein Human genes 0.000 claims description 19
108700020942 nucleic acid binding protein Proteins 0.000 claims description 19
238000003786 synthesis reaction Methods 0.000 claims description 19
102100023995 Beta-nerve growth factor Human genes 0.000 claims description 18
108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 18
102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 18
108010025020 Nerve Growth Factor Proteins 0.000 claims description 18
102000003978 Tissue Plasminogen Activator Human genes 0.000 claims description 18
108090000373 Tissue Plasminogen Activator Proteins 0.000 claims description 18
238000003556 assay Methods 0.000 claims description 18
229940053128 nerve growth factor Drugs 0.000 claims description 18
229960000187 tissue plasminogen activator Drugs 0.000 claims description 18
230000000295 complement effect Effects 0.000 claims description 17
238000001514 detection method Methods 0.000 claims description 17
238000012986 modification Methods 0.000 claims description 17
230000004048 modification Effects 0.000 claims description 17
108090000190 Thrombin Proteins 0.000 claims description 16
229960004072 thrombin Drugs 0.000 claims description 16
101800004538 Bradykinin Proteins 0.000 claims description 15
102400000967 Bradykinin Human genes 0.000 claims description 15
101710132601 Capsid protein Proteins 0.000 claims description 14
101710094648 Coat protein Proteins 0.000 claims description 14
102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 14
QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims description 14
101710125418 Major capsid protein Proteins 0.000 claims description 14
101710141454 Nucleoprotein Proteins 0.000 claims description 14
101710083689 Probable capsid protein Proteins 0.000 claims description 14
239000003795 chemical substances by application Substances 0.000 claims description 14
238000012163 sequencing technique Methods 0.000 claims description 14
QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical group NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims description 12
150000001875 compounds Chemical class 0.000 claims description 12
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims description 12
238000002405 diagnostic procedure Methods 0.000 claims description 12
102000004196 processed proteins & peptides Human genes 0.000 claims description 12
239000000523 sample Substances 0.000 claims description 12
238000010367 cloning Methods 0.000 claims description 11
239000003814 drug Substances 0.000 claims description 11
238000012216 screening Methods 0.000 claims description 11
101000976075 Homo sapiens Insulin Proteins 0.000 claims description 10
108020004682 Single-Stranded DNA Proteins 0.000 claims description 10
241000700605 Viruses Species 0.000 claims description 10
239000002253 acid Substances 0.000 claims description 10
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical group C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims description 10
102000040430 polynucleotide Human genes 0.000 claims description 10
108091033319 polynucleotide Proteins 0.000 claims description 10
239000002157 polynucleotide Substances 0.000 claims description 10
238000000746 purification Methods 0.000 claims description 10
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical class O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 8
239000003102 growth factor Substances 0.000 claims description 8
239000002207 metabolite Substances 0.000 claims description 8
230000008827 biological function Effects 0.000 claims description 7
150000001720 carbohydrates Chemical class 0.000 claims description 7
235000014633 carbohydrates Nutrition 0.000 claims description 7
238000004519 manufacturing process Methods 0.000 claims description 7
230000007246 mechanism Effects 0.000 claims description 7
230000004853 protein function Effects 0.000 claims description 7
239000003352 sequestering agent Substances 0.000 claims description 7
238000006467 substitution reaction Methods 0.000 claims description 7
108090000288 Glycoproteins Proteins 0.000 claims description 6
102000003886 Glycoproteins Human genes 0.000 claims description 6
230000009471 action Effects 0.000 claims description 6
239000003153 chemical reaction reagent Substances 0.000 claims description 6
229940104302 cytosine Drugs 0.000 claims description 6
108010005905 delta-hGHR Proteins 0.000 claims description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
229940079593 drug Drugs 0.000 claims description 6
230000002349 favourable effect Effects 0.000 claims description 6
150000004676 glycans Chemical class 0.000 claims description 6
238000001727 in vivo Methods 0.000 claims description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
230000035790 physiological processes and functions Effects 0.000 claims description 6
229920001282 polysaccharide Polymers 0.000 claims description 6
239000005017 polysaccharide Substances 0.000 claims description 6
230000001225 therapeutic effect Effects 0.000 claims description 6
239000003053 toxin Substances 0.000 claims description 6
231100000765 toxin Toxicity 0.000 claims description 6
108700012359 toxins Proteins 0.000 claims description 6
230000007704 transition Effects 0.000 claims description 6
UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical group CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims description 5
229930182837 (R)-adrenaline Natural products 0.000 claims description 5
241000709747 Enterobacteria phage R17 Species 0.000 claims description 5
108010088842 Fibrinolysin Proteins 0.000 claims description 5
108010067372 Pancreatic elastase Proteins 0.000 claims description 5
102000016387 Pancreatic elastase Human genes 0.000 claims description 5
102000035195 Peptidases Human genes 0.000 claims description 5
108091005804 Peptidases Proteins 0.000 claims description 5
239000004365 Protease Substances 0.000 claims description 5
AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 claims description 5
108090000631 Trypsin Proteins 0.000 claims description 5
102000004142 Trypsin Human genes 0.000 claims description 5
229960005139 epinephrine Drugs 0.000 claims description 5
230000011987 methylation Effects 0.000 claims description 5
238000007069 methylation reaction Methods 0.000 claims description 5
235000015097 nutrients Nutrition 0.000 claims description 5
229940012957 plasmin Drugs 0.000 claims description 5
238000003752 polymerase chain reaction Methods 0.000 claims description 5
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
229940124597 therapeutic agent Drugs 0.000 claims description 5
239000005495 thyroid hormone Substances 0.000 claims description 5
229940036555 thyroid hormone Drugs 0.000 claims description 5
239000012588 trypsin Substances 0.000 claims description 5
229940035893 uracil Drugs 0.000 claims description 5
238000002560 therapeutic procedure Methods 0.000 claims description 4
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 3
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 3
102000004877 Insulin Human genes 0.000 claims description 3
108090001061 Insulin Proteins 0.000 claims description 3
238000012377 drug delivery Methods 0.000 claims description 3
229940125396 insulin Drugs 0.000 claims description 3
239000003607 modifier Substances 0.000 claims description 3
102000014914 Carrier Proteins Human genes 0.000 claims description 2
208000007536 Thrombosis Diseases 0.000 claims description 2
150000001412 amines Chemical class 0.000 claims description 2
108091008324 binding proteins Proteins 0.000 claims description 2
230000023555 blood coagulation Effects 0.000 claims description 2
238000007385 chemical modification Methods 0.000 claims description 2
208000035475 disorder Diseases 0.000 claims description 2
229920002477 rna polymer Polymers 0.000 claims 17
108090000317 Chymotrypsin Proteins 0.000 claims 4
239000000427 antigen Substances 0.000 claims 4
102000036639 antigens Human genes 0.000 claims 4
108091007433 antigens Proteins 0.000 claims 4
229960002376 chymotrypsin Drugs 0.000 claims 4
108010001857 Cell Surface Receptors Proteins 0.000 claims 2
102000000844 Cell Surface Receptors Human genes 0.000 claims 2
229940039227 diagnostic agent Drugs 0.000 claims 2
239000000032 diagnostic agent Substances 0.000 claims 2
238000003745 diagnosis Methods 0.000 claims 1
230000009897 systematic effect Effects 0.000 abstract description 3
239000000243 solution Substances 0.000 description 96
238000002474 experimental method Methods 0.000 description 70
101000906736 Escherichia phage Mu DNA circularization protein N Proteins 0.000 description 47
101000764570 Streptomyces phage phiC31 Probable tape measure protein Proteins 0.000 description 47
239000000020 Nitrocellulose Substances 0.000 description 45
229920001220 nitrocellulos Polymers 0.000 description 45
239000013615 primer Substances 0.000 description 41
102100031780 Endonuclease Human genes 0.000 description 39
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 39
238000006243 chemical reaction Methods 0.000 description 33
239000002299 complementary DNA Substances 0.000 description 26
230000003993 interaction Effects 0.000 description 23
241000894007 species Species 0.000 description 22
108091034117 Oligonucleotide Proteins 0.000 description 21
108020004566 Transfer RNA Proteins 0.000 description 21
239000000126 substance Substances 0.000 description 20
239000000047 product Substances 0.000 description 19
241000713772 Human immunodeficiency virus 1 Species 0.000 description 17
239000012148 binding buffer Substances 0.000 description 17
230000010076 replication Effects 0.000 description 17
238000000159 protein binding assay Methods 0.000 description 15
230000005764 inhibitory process Effects 0.000 description 14
108010078851 HIV Reverse Transcriptase Proteins 0.000 description 13
238000006555 catalytic reaction Methods 0.000 description 13
238000013518 transcription Methods 0.000 description 13
230000035897 transcription Effects 0.000 description 13
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 12
150000003839 salts Chemical class 0.000 description 11
150000003384 small molecules Chemical class 0.000 description 11
238000010494 dissociation reaction Methods 0.000 description 10
230000005593 dissociations Effects 0.000 description 10
239000000499 gel Substances 0.000 description 10
108020004999 messenger RNA Proteins 0.000 description 10
238000004458 analytical method Methods 0.000 description 9
108700004025 env Genes Proteins 0.000 description 9
239000011159 matrix material Substances 0.000 description 9
238000012408 PCR amplification Methods 0.000 description 8
101710150344 Protein Rev Proteins 0.000 description 8
229920002684 Sepharose Polymers 0.000 description 8
241000700584 Simplexvirus Species 0.000 description 8
150000001413 amino acids Chemical class 0.000 description 8
230000008901 benefit Effects 0.000 description 8
238000010804 cDNA synthesis Methods 0.000 description 8
238000010276 construction Methods 0.000 description 8
238000010586 diagram Methods 0.000 description 8
238000010790 dilution Methods 0.000 description 8
239000012895 dilution Substances 0.000 description 8
108010026228 mRNA guanylyltransferase Proteins 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
108090000994 Catalytic RNA Proteins 0.000 description 7
102000053642 Catalytic RNA Human genes 0.000 description 7
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 7
239000010931 gold Substances 0.000 description 7
230000000717 retained effect Effects 0.000 description 7
108091092562 ribozyme Proteins 0.000 description 7
239000002904 solvent Substances 0.000 description 7
108020005098 Anticodon Proteins 0.000 description 6
241000701533 Escherichia virus T4 Species 0.000 description 6
101900297506 Human immunodeficiency virus type 1 group M subtype B Reverse transcriptase/ribonuclease H Proteins 0.000 description 6
230000004570 RNA-binding Effects 0.000 description 6
235000001014 amino acid Nutrition 0.000 description 6
239000000872 buffer Substances 0.000 description 6
238000001914 filtration Methods 0.000 description 6
239000012634 fragment Substances 0.000 description 6
239000000833 heterodimer Substances 0.000 description 6
239000000543 intermediate Substances 0.000 description 6
239000002777 nucleoside Substances 0.000 description 6
241001463143 Auca Species 0.000 description 5
102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 5
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 5
241000588724 Escherichia coli Species 0.000 description 5
241000725303 Human immunodeficiency virus Species 0.000 description 5
230000008859 change Effects 0.000 description 5
230000001351 cycling effect Effects 0.000 description 5
238000009826 distribution Methods 0.000 description 5
230000001976 improved effect Effects 0.000 description 5
230000006872 improvement Effects 0.000 description 5
230000014759 maintenance of location Effects 0.000 description 5
230000035772 mutation Effects 0.000 description 5
238000005457 optimization Methods 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
238000010187 selection method Methods 0.000 description 5
238000000926 separation method Methods 0.000 description 5
239000001226 triphosphate Substances 0.000 description 5
235000011178 triphosphate Nutrition 0.000 description 5
108091035707 Consensus sequence Proteins 0.000 description 4
108700020121 Human Immunodeficiency Virus-1 rev Proteins 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
238000000137 annealing Methods 0.000 description 4
230000000875 corresponding effect Effects 0.000 description 4
201000010099 disease Diseases 0.000 description 4
238000010828 elution Methods 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
238000002703 mutagenesis Methods 0.000 description 4
231100000350 mutagenesis Toxicity 0.000 description 4
230000036961 partial effect Effects 0.000 description 4
235000011056 potassium acetate Nutrition 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
230000009467 reduction Effects 0.000 description 4
210000003705 ribosome Anatomy 0.000 description 4
238000013519 translation Methods 0.000 description 4
241001515965 unidentified phage Species 0.000 description 4
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 3
239000003155 DNA primer Substances 0.000 description 3
230000006820 DNA synthesis Effects 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
102000003746 Insulin Receptor Human genes 0.000 description 3
108010001127 Insulin Receptor Proteins 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
108060004795 Methyltransferase Proteins 0.000 description 3
108091005461 Nucleic proteins Proteins 0.000 description 3
101710137500 T7 RNA polymerase Proteins 0.000 description 3
238000002441 X-ray diffraction Methods 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
239000002131 composite material Substances 0.000 description 3
108091036078 conserved sequence Proteins 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000014509 gene expression Effects 0.000 description 3
238000010348 incorporation Methods 0.000 description 3
238000011534 incubation Methods 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
238000007689 inspection Methods 0.000 description 3
238000012804 iterative process Methods 0.000 description 3
239000000463 material Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
239000012528 membrane Substances 0.000 description 3
150000003833 nucleoside derivatives Chemical class 0.000 description 3
125000003835 nucleoside group Chemical group 0.000 description 3
229920001184 polypeptide Polymers 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
230000003362 replicative effect Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
238000010839 reverse transcription Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
239000007858 starting material Substances 0.000 description 3
230000002103 transcriptional effect Effects 0.000 description 3
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 3
238000005406 washing Methods 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
XGWFJBFNAQHLEF-UHFFFAOYSA-N 9-anthroic acid Chemical compound C1=CC=C2C(C(=O)O)=C(C=CC=C3)C3=CC2=C1 XGWFJBFNAQHLEF-UHFFFAOYSA-N 0.000 description 2
102000012440 Acetylcholinesterase Human genes 0.000 description 2
108010022752 Acetylcholinesterase Proteins 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
108010051479 Bombesin Proteins 0.000 description 2
102000013585 Bombesin Human genes 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
108020001019 DNA Primers Proteins 0.000 description 2
230000004543 DNA replication Effects 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
241001125671 Eretmochelys imbricata Species 0.000 description 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
102000002265 Human Growth Hormone Human genes 0.000 description 2
108010000521 Human Growth Hormone Proteins 0.000 description 2
239000000854 Human Growth Hormone Substances 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
108091030071 RNAI Proteins 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
101150099321 UL42 gene Proteins 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
229940022698 acetylcholinesterase Drugs 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
239000012190 activator Substances 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
230000004075 alteration Effects 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
150000001768 cations Chemical class 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
230000009137 competitive binding Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
108091006104 gene-regulatory proteins Proteins 0.000 description 2
102000034356 gene-regulatory proteins Human genes 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
229920001519 homopolymer Polymers 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
238000013383 initial experiment Methods 0.000 description 2
238000002372 labelling Methods 0.000 description 2
239000012038 nucleophile Substances 0.000 description 2
238000005192 partition Methods 0.000 description 2
239000013612 plasmid Substances 0.000 description 2
235000004252 protein component Nutrition 0.000 description 2
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 2
150000003230 pyrimidines Chemical class 0.000 description 2
239000011535 reaction buffer Substances 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
108010033826 ribosomal protein S1 Proteins 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000002741 site-directed mutagenesis Methods 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
230000008093 supporting effect Effects 0.000 description 2
102000010521 tRNA (m5U54) methyltransferase activity proteins Human genes 0.000 description 2
108040005331 tRNA (m5U54) methyltransferase activity proteins Proteins 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
238000012546 transfer Methods 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 1
CZMRCDWAGMRECN-UHFFFAOYSA-N 2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
101710192507 30S ribosomal protein S1 Proteins 0.000 description 1
BBZZGDLNBVRFFI-UHFFFAOYSA-N 4,5-dihydropyrimidine Chemical compound C1CN=CN=C1 BBZZGDLNBVRFFI-UHFFFAOYSA-N 0.000 description 1
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
102100027271 40S ribosomal protein SA Human genes 0.000 description 1
LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical class BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 description 1
VWEWCZSUWOEEFM-WDSKDSINSA-N Ala-Gly-Ala-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(O)=O VWEWCZSUWOEEFM-WDSKDSINSA-N 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 1
108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 1
108010064733 Angiotensins Proteins 0.000 description 1
102000015427 Angiotensins Human genes 0.000 description 1
102000006306 Antigen Receptors Human genes 0.000 description 1
108010083359 Antigen Receptors Proteins 0.000 description 1
101100437118 Arabidopsis thaliana AUG1 gene Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
108010024957 Ascorbate Oxidase Proteins 0.000 description 1
102100039339 Atrial natriuretic peptide receptor 1 Human genes 0.000 description 1
101710102163 Atrial natriuretic peptide receptor 1 Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
101100002344 Caenorhabditis elegans arid-1 gene Proteins 0.000 description 1
241000282461 Canis lupus Species 0.000 description 1
108090000565 Capsid Proteins Proteins 0.000 description 1
241000905957 Channa melasoma Species 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
206010010144 Completed suicide Diseases 0.000 description 1
UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
102000052510 DNA-Binding Proteins Human genes 0.000 description 1
108700020911 DNA-Binding Proteins Proteins 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
108010092160 Dactinomycin Proteins 0.000 description 1
101100316028 Drosophila melanogaster Uggt gene Proteins 0.000 description 1
101100004648 Drosophila melanogaster brat gene Proteins 0.000 description 1
241000701832 Enterobacteria phage T3 Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
241001123946 Gaga Species 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
RTDFOQVLLJZRIH-JZAVHCKJSA-N Glycoursocholanic acid Chemical compound C([C@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)CC1 RTDFOQVLLJZRIH-JZAVHCKJSA-N 0.000 description 1
102000009465 Growth Factor Receptors Human genes 0.000 description 1
108010009202 Growth Factor Receptors Proteins 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
102100033969 Guanylyl cyclase-activating protein 1 Human genes 0.000 description 1
102000002268 Hexosaminidases Human genes 0.000 description 1
108010000540 Hexosaminidases Proteins 0.000 description 1
101001068480 Homo sapiens Guanylyl cyclase-activating protein 1 Proteins 0.000 description 1
206010020850 Hyperthyroidism Diseases 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
101150002998 LCAT gene Proteins 0.000 description 1
241000594011 Leuciscus leuciscus Species 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
102000016397 Methyltransferase Human genes 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
241000270276 Natrix Species 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
241000283216 Phocidae Species 0.000 description 1
102000002067 Protein Subunits Human genes 0.000 description 1
108010001267 Protein Subunits Proteins 0.000 description 1
108700020471 RNA-Binding Proteins Proteins 0.000 description 1
102000044126 RNA-Binding Proteins Human genes 0.000 description 1
101100273253 Rhizopus niveus RNAP gene Proteins 0.000 description 1
108010057163 Ribonuclease III Proteins 0.000 description 1
108090000621 Ribonuclease P Proteins 0.000 description 1
102000004167 Ribonuclease P Human genes 0.000 description 1
108010046983 Ribonuclease T1 Proteins 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
108010000605 Ribosomal Proteins Proteins 0.000 description 1
102000002278 Ribosomal Proteins Human genes 0.000 description 1
108091006629 SLC13A2 Proteins 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
102000013275 Somatomedins Human genes 0.000 description 1
241000529895 Stercorarius Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
101100049199 Xenopus laevis vegt-a gene Proteins 0.000 description 1
108091027569 Z-DNA Proteins 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
125000005001 aminoaryl group Chemical group 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000009697 arginine Nutrition 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
230000001746 atrial effect Effects 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
238000000211 autoradiogram Methods 0.000 description 1
230000010455 autoregulation Effects 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000008364 bulk solution Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
108091092328 cellular RNA Proteins 0.000 description 1
210000003850 cellular structure Anatomy 0.000 description 1
210000002230 centromere Anatomy 0.000 description 1
238000002144 chemical decomposition reaction Methods 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
101150087654 chrnd gene Proteins 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
239000005516 coenzyme A Substances 0.000 description 1
229940093530 coenzyme a Drugs 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000009918 complex formation Effects 0.000 description 1
238000005094 computer simulation Methods 0.000 description 1
239000000599 controlled substance Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
239000013078 crystal Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
229960000640 dactinomycin Drugs 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
238000013461 design Methods 0.000 description 1
238000007865 diluting Methods 0.000 description 1
102000022788 double-stranded DNA binding proteins Human genes 0.000 description 1
108091013637 double-stranded DNA binding proteins Proteins 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
239000000975 dye Substances 0.000 description 1
239000012636 effector Substances 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
229940125532 enzyme inhibitor Drugs 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
239000000835 fiber Substances 0.000 description 1
235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000009368 gene silencing by RNA Effects 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
230000002218 hypoglycaemic effect Effects 0.000 description 1
230000003053 immunization Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
NDDAHWYSQHTHNT-UHFFFAOYSA-N indapamide Chemical compound CC1CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 NDDAHWYSQHTHNT-UHFFFAOYSA-N 0.000 description 1
239000003999 initiator Substances 0.000 description 1
238000011835 investigation Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000000622 liquid--liquid extraction Methods 0.000 description 1
235000018977 lysine Nutrition 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
210000004898 n-terminal fragment Anatomy 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
230000018791 negative regulation of catalytic activity Effects 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
150000005480 nicotinamides Chemical class 0.000 description 1
FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
238000001821 nucleic acid purification Methods 0.000 description 1
238000011330 nucleic acid test Methods 0.000 description 1
230000001293 nucleolytic effect Effects 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
229940046166 oligodeoxynucleotide Drugs 0.000 description 1
238000012856 packing Methods 0.000 description 1
239000003973 paint Substances 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
230000018767 positive regulation of catalytic activity Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000006916 protein interaction Effects 0.000 description 1
230000003161 proteinsynthetic effect Effects 0.000 description 1
238000012207 quantitative assay Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
206010037844 rash Diseases 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
230000014493 regulation of gene expression Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000012552 review Methods 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
239000002002 slurry Substances 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
238000009987 spinning Methods 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
102000055501 telomere Human genes 0.000 description 1
108091035539 telomere Proteins 0.000 description 1
210000003411 telomere Anatomy 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
230000036964 tight binding Effects 0.000 description 1
238000004448 titration Methods 0.000 description 1
108091006106 transcriptional activators Proteins 0.000 description 1
108091006107 transcriptional repressors Proteins 0.000 description 1
238000006276 transfer reaction Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1